Breast Cancer

The serum HER-2/neu Test and Metastatic Breast Cancer

Serum HER-2

serum HER-2/neu: Helping Women with Metastatic Breast Cancer

The serum HER-2/neu test is a simple blood test for over 150,000 women living with metastatic breast cancer.1 For the thousands of women diagnosed with metastatic breast cancer each year, the Siemens serum HER-2/neu test is the automated serum HER-2/neu test available for sale in the U.S. for monitoring their Serum HER-2/neu status during therapy. The serum HER-2/neu test is indicated for follow-up and monitoring patients with metastatic breast cancer and initial serum level >15 ng/mL.

serum HER-2/neu Status: Providing Critical Information for Metastatic Disease Assessment

Less than 15% increase is considered to indicate a lack of progression. Increase of equal or greater than 15% was considered to indicate progression.*

Monitoring serum HER-2/neu levels yields important information about response to therapy and cancer progression, and may help physicians make more informed decisions when developing and modifying patient treatment regimen. 2-4  

Subscription Button Icon
Be the first to know about our events, training, and news